Susquehanna International Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Susquehanna International Group’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,313	Closed	-$6.13K	–	13784
2023 Q3	$6.13K	Buy	+15,313	New	+$7.54K	﹤0.01%	11762
2022 Q4	–	Sell	-14,663	Closed	-$16K	–	14688
2022 Q3	$16K	Buy	14,663 +328	+2%	+$429	﹤0.01%	12692
2022 Q2	$18K	Buy	+14,335	New	+$19.2K	﹤0.01%	12396
2017 Q3	–	Sell	-65,456	Closed	-$1.32M	–	10010
2017 Q2	$1.32M	Buy	+65,456	New	+$1.35M	﹤0.01%	4700

Other funds holding BLPH

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Susquehanna International Group's BLPH Position: Q4 2023 in Review

Susquehanna International Group sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 15,313 shares — an estimated $6.13K sold.

Susquehanna International Group first reported a position in BLPH in Q2 2017 and held it in 4 quarters. The position peaked at $1.32M in Q2 2017. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

Susquehanna International Group reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 15,313 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $6.13K.
Susquehanna International Group first reported a position in Bellerophon Therapeutics, Inc. in Q2 2017 and held it in 4 quarters.
Susquehanna International Group's Bellerophon Therapeutics, Inc. position peaked at $1.32M in Q2 2017.
2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.